These consensus guidelines are significant not only for their key updates to clinical practice but for their representation of a more unified, global approach to diagnosing and monitoring patients with multiple sclerosis.
For the first time, experts in multiple sclerosis (MS) from North America and Europe have aligned on consensus recommendations for the use of MRI in people with MS. These guidelines—developed by the Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) study group; the Consortium of Multiple Sclerosis Centers (CMSC) working group; and the North America Imaging in Multiple Sclerosis (NAIMS) MRI Guidelines working group—address recent advancements in imaging technology and new safety data, among other clinical updates. [more]
Written by: Alicia Bigica
